Page last updated: 2024-08-26

3-(2-carboxypiperazine-4-yl)-1-propenyl-1-phosphonic acid and ro 25-6981

3-(2-carboxypiperazine-4-yl)-1-propenyl-1-phosphonic acid has been researched along with ro 25-6981 in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Lanis, A; Schmidt, WJ1
Bevins, RA; Murray, JE; Polewan, RJ; Walker, AW1

Other Studies

2 other study(ies) available for 3-(2-carboxypiperazine-4-yl)-1-propenyl-1-phosphonic acid and ro 25-6981

ArticleYear
NMDA receptor antagonists do not block the development of sensitization of catalepsy, but make its expression state-dependent.
    Behavioural pharmacology, 2001, Volume: 12, Issue:2

    Topics: Animals; Conditioning, Classical; Drug Interactions; Excitatory Amino Acid Antagonists; Haloperidol; Male; Phenols; Piperazines; Piperidines; Rats; Rats, Sprague-Dawley; Receptors, Dopamine; Receptors, N-Methyl-D-Aspartate

2001
An examination of NMDA receptor contribution to conditioned responding evoked by the conditional stimulus effects of nicotine.
    Psychopharmacology, 2011, Volume: 213, Issue:1

    Topics: 2-Amino-5-phosphonovalerate; Animals; Brain; Conditioning, Classical; Cyclopentanes; Discrimination, Psychological; Dizocilpine Maleate; Dose-Response Relationship, Drug; Drug Interactions; Excitatory Amino Acid Antagonists; Male; Mecamylamine; N-Methylaspartate; Nicotine; Phencyclidine; Phenols; Piperazines; Piperidines; Quinolones; Rats; Rats, Sprague-Dawley; Receptors, N-Methyl-D-Aspartate

2011